MRNA Apr 2024 70.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:38AM EDT. Market open.
| Previous close | 41.90 |
| Open | 37.30 |
| Bid | 38.10 |
| Ask | 38.70 |
| Strike | 70.00 |
| Expiry date | 2024-04-19 |
| Day's range | 37.25 - 37.30 |
| Contract range | N/A |
| Volume | |
| Open interest | 18 |
Motley FoolIf I Could Only Buy 3 Stocks in 2023, I'd Pick These
CRISPR Therapeutics (NASDAQ: CRSP) specializes in gene editing, or the repair of faulty genes responsible for disease. Right now, CRISPR is heading for its biggest moment ever -- a regulatory decision on what may become its first commercialized product. The U.S. Food and Drug Administration (FDA) is set to decide on exa-cel for sickle cell disease in December and on exa-cel for beta thalassemia in March.
ZacksIs it Time to Buy Pfizer, Moderna, or AstraZeneca's Stock?
Despite slowing COVID-19 vaccine sales these healthcare titans are trading at more reasonable valuations with a lot of the risk-to-reward being priced into their stocks considering their earnings potential.
ZacksModerna (MRNA) Outpaces Stock Market Gains: What You Should Know
In the latest trading session, Moderna (MRNA) closed at $100.27, marking a +0.83% move from the previous day.
© 2023 Yahoo. All rights reserved.
